nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.02.2011 | Image of the Month

Reversible brain hypometabolism associated with central nervous system systemic lupus erythematosus

verfasst von: Jukka Kemppainen, Sami Kajander, Timo Yli-Kerttula, Laura Airas, Marko Seppänen

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Excerpt

A 63-year-old woman with a history of hypothyroidism and rheumatoid arthritis was referred to the internal medicine department due to progressive muscle fatigue, weight loss of 15 kg, haemolytic anaemia, fever and memory impairment. The Mini-Mental State Examination was abnormal (MMSE 16/30). The initial brain MRI showed general cortical atrophy and FDG PET suggested a neurodegenerative disease with symmetrical severe hypometabolism in the frontal, parietal and temporal cortexes. Neurological consultation did not lead to a specific diagnosis. Later antinuclear antibody serological tests were indicative of systemic lupus erythematosus (SLE) [1‐5]. The patient was treated with high-dose corticosteroids and cyclophosphamide. …

Kao CH, Lan JL, ChangLai SP, Liao KK, Yen RF, Chieng PU. The role of FDG-PET, HMPAO-SPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus. Eur J Nucl Med 1999;26(2):129–34.CrossRefPubMed

Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer’s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995;36(7):1238–48.PubMed

Otte A, Weiner SM, Peter HH, Mueller-Brand J, Goetze M, Moser E, et al. Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study. Eur J Nucl Med 1997;24(7):787–91.PubMed

Sailer M, Burchert W, Ehrenheim C, Smid HG, Haas J, Wildhagen K, et al. Positron emission tomography and magnetic resonance imaging for cerebral involvement in patients with systemic lupus erythematosus. J Neurol 1997;244(3):186–93.CrossRefPubMed

Weiner SM, Otte A, Schumacher M, Klein R, Gutfleisch J, Brink I, et al. Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann Rheum Dis 2000;59(5):377–85.CrossRefPubMed

Titel: Reversible brain hypometabolism associated with central nervous system systemic lupus erythematosus
verfasst von: Jukka Kemppainen
Sami Kajander
Timo Yli-Kerttula
Laura Airas
Marko Seppänen
Publikationsdatum: 01.02.2011
Verlag: Springer-Verlag
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 2/2011
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-010-1652-5

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Reversible brain hypometabolism associated with central nervous system systemic lupus erythematosus

Excerpt

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2011

177Lu-immunotherapy of experimental peritoneal carcinomatosis shows comparable effectiveness to 213Bi-immunotherapy, but causes toxicity not observed with 213Bi

Molecular imaging in cancer treatment

Can multimodality imaging using 18F-FDG/18F-FLT PET/CT benefit the diagnosis and management of patients with pulmonary lesions?

In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer’s disease

Phase II study of radiopeptide 177Lu-octreotate and capecitabine therapy of progressive disseminated neuroendocrine tumours

Current research in nuclear medicine and molecular imaging: highlights of the 23rd Annual EANM Congress